Maternal infection during pregnancy is a significant risk factor for future mental
disorders in offspring. This phenomenon is studied translationally using maternal
immune activation (MIA) models. Dopamine (DA) dysregulation is a feature of some MIA
model systems. We previously reported increased striatal DA synthesis capacity in
a pilot MIA NHP cohort. In the present study, we report data on the relationship between
[18F] fluoro-l-m-tyrosine (FMT) PET measures in the striatum and substantia nigra
(SN) neuromelanin (NM; a putative noninvasive proxy DA measure) levels in MIA NHP’s.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2022 Published by Elsevier Inc.